Loading clinical trials...

RISI in the Treatment of Recurrent Chest Wall Malignancies After EBRT | Clinical Trials | Clareo Health

UNKNOWNNCT04077710

RISI in the Treatment of Recurrent Chest Wall Malignancies After EBRT

This study will observe the efficacy and toxicities of 3-dimensional printing noncoplanar template assisted CT guided radioactive iodine-125 seeds implantation in the treatment of patients with recurr...

Lead sponsor: Peking University Third Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Zhe Ji, M.D.

CONTACT

008618710002823 aschoff@163.com

Related studies

COMPLETED

Institutional Experience With Chest Wall Reconstruction Using Sternal Steel Wires: A Case Series Study

NCT07148648 · Chest Wall Mechanics, Chest Wall Deformity, and more

Not Yet RecruitingNA

Artificial Intelligence Combined With 3D-Preformed Chest Wall Defection Reconstruction System in Chest Wall Tumor Surgery

NCT06978075 · Chest Wall Tumor, Reconstruction Surgery

COMPLETEDPhase 3

Effects of Oral Aloe Vera Juice on Chemotherapy and Radiation-induced Oral Mucositis and Esophagitis

NCT05369234 · Oral Cavity Cancer, Head and Neck Cancers - Tonsils, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 27, 2023Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment30

Start dateMay 2020

Last updatedDec 27, 2023

Condition

Chest Wall Tumor

Locations shown

Peking University Third Hospital

Beijing, Beijing Municipality

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 27, 2023Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions